InsidersTradesSigma
Follow the Seaport Therapeutics, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €1.3bn. The latest transaction was disclosed on 24 June 2026 (Acquisition). Among the most active insiders: HOMBACH ROBERT J.. The full history is openly available.
Analysts rate Seaport Therapeutics, Inc. Strong Buy (bullish), based on 5 analysts. Average price target: US$38.00.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Seaport Therapeutics, Inc. is a company focused on developing innovative therapies. It specializes in the research and commercialization of treatments for serious diseases.